GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » 5-Year Yield-on-Cost %

Laurus Labs (BOM:540222) 5-Year Yield-on-Cost % : 1.02 (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs 5-Year Yield-on-Cost %?

Laurus Labs's yield on cost for the quarter that ended in Mar. 2024 was 1.02.


The historical rank and industry rank for Laurus Labs's 5-Year Yield-on-Cost % or its related term are showing as below:

BOM:540222' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.79   Med: 2.15   Max: 4.97
Current: 1.02


During the past 11 years, Laurus Labs's highest Yield on Cost was 4.97. The lowest was 0.79. And the median was 2.15.


BOM:540222's 5-Year Yield-on-Cost % is ranked worse than
75.55% of 503 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs BOM:540222: 1.02

Competitive Comparison of Laurus Labs's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Laurus Labs's 5-Year Yield-on-Cost % falls into.



Laurus Labs 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Laurus Labs is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Laurus Labs  (BOM:540222) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Laurus Labs 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Laurus Labs's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines